Laborclin
Laborclin, a Brazilian manufacturer founded in 1968 and now a subsidiary of France's Grupo Solabia, produces and distributes more than 600 microbiology and diagnostic products — culture media, chromogenic tests, automated blood culture systems, and biochemical identification kits — to clinical laboratories, food and beverage manufacturers, and veterinary and research institutions across Brazil and Latin America.
- Company typePrivate
- Founded1968
- HeadquartersPinhais, Brazil
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Laborclin does
Laborclin is a Brazilian manufacturer and distributor of microbiological diagnostic and quality-control products headquartered in Pinhais, Paraná. Founded in 1968, the company offers a portfolio of more than 600 products spanning five business segments: Clínica (clinical diagnostics), Indústria (industrial microbiology for food, beverage, and cosmetics), Veterinária (veterinary diagnostics), Hemocultura Automatizada (automated blood culture), and Meios Liofilizados (lyophilized culture media). Core technology centers on culture media formulations, chromogenic substrate mixtures (e.g., Cromoclin), biochemical identification test kits (Bactray I/II/III, 30 substrates with online data interpretation software), automated blood culture instruments using CO2 and pH detection (BacTime BC32 and BC128), and rapid immunoassays for carbapenemase detection (NG-Test CARBA 5).
The business is a B2B sales-led operation targeting clinical laboratories, hospitals, food and beverage manufacturers, cosmetics producers, veterinary labs, and biological research institutions across Brazil and Latin America. Revenue is generated through direct sales by an in-house commercial team and a network of state-level regional distributors across Brazil (including Dislab, Interlab, BioSave, Enzipharma, Calmed, Diaglab, Centrallab). Pricing is opaque and quote-based via phone, WhatsApp, and a customer service (SAC) portal. The portfolio is broadened by an exclusive representation agreement with Biokar Diagnostics for lyophilized culture media.
Since March 2020, Laborclin has been a wholly-owned subsidiary of French conglomerate Grupo Solabia, which operates nine production units across France, Brazil, Israel, and the United States and distributes in more than 80 countries. The Solabia ownership has driven investment in automation, R&D, and the recent integration of sister Brazilian entity Plastlabor under a unified @solabia.com corporate identity from February 2025. The company is BPF (Good Manufacturing Practices) certified and reports a workforce of more than 300 employees.
Laborclin firmographics
Firmographics- Name
- Laborclin
- Legal name
- Laborclin
- Website
- https://laborclin.com.br
- Company type
- Private
- Founded year
- 1968
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Laborclin, a Brazilian manufacturer founded in 1968 and now a subsidiary of France's Grupo Solabia, produces and distributes more than 600 microbiology and diagnostic products — culture media, chromogenic tests, automated blood culture systems, and biochemical identification kits — to clinical laboratories, food and beverage manufacturers, and veterinary and research institutions across Brazil and Latin America.
- Ownership category
- akta.pro rank
Laborclin industry classification
Industry- Product category
- In Vitro Microbiology Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)
- akta.pro secondary industries
- Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Microbiological Reference Cultures, Strains & Controls (Food Micro) (AFALAKAF)
Keywords
Where Laborclin is headquartered
LocationHeadquarters
- HQ city
- Pinhais
- HQ country
- Brazil
- HQ region
- Latin America
Offices2 records
Markets served
Laborclin business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic and Microbiology Products: Sale of culture media, reagents, chromogenic media, swabs, biochemical test kits, and automated blood culture equipment and consumables to clinical laboratories and industries.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Laborclin product offering
Product offeringCore offering
Laborclin manufactures and distributes a portfolio of more than 600 microbiological diagnostic products including dehydrated and chromogenic culture media, diagnostic reagents, biochemical identification kits, automated blood culture instruments (BacTime), rapid immunoassays (NG-Test CARBA 5), sterile sample collection swabs, and lyophilized media distributed under the Biokar Diagnostics brand. Products serve clinical analysis laboratories, hospital diagnostics, food and beverage quality control, cosmetics manufacturing, veterinary diagnostics, and biological research across Brazil and Latin America.
Product overview
Laborclin is a laboratory diagnostics and microbiology products company offering over 600 products across five business segments: Clínica (clinical diagnostics), Indústria (industrial quality control), Veterinária (veterinary), Hemocultura Automatizada (automated blood culture), and Meios Liofilizados (lyophilized media). The portfolio centers on culture media, reagents, stains, biochemical test systems (Bactray), automated blood culture instruments (Bactime), rapid diagnostic tests (NG-Test CARBA 5), sample collection devices (Copan swabs), and alternative microbiological methods. The company operates as part of Grupo Solabia following acquisition in 2020, with products distributed exclusively in Brazil and Latin America. The Bactray system includes online software for data access; Bactime provides automated blood culture with aerobic, anaerobic, pediatric, and fastidious culture bottles; NG-Test CARBA 5 offers rapid carbapenemase detection; and Biokar Diagnostics products (from Solabia Group) extend the lyophilized media portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Bactime: Automated blood culture system that detects CO2 production through color change of bottle bottom and pH changes
- Biokar Diagnostics
- Cromoclin
- NG-Test CARBA 5
- Aquateste Coli
- Bactray
Products and services
- Copan Swabs Sterile swab devices for microbiological sample collection and transport, including flocked, rayon, and medium-containing variants (Amies, Stuart, Cary Blair, SRK) for clinical and environmental applications. Distributed from the Copan brand.
- Listeria ALOA Agar Chromogenic culture medium for isolation and identification of Listeria monocytogenes and Listeria spp. in food and environmental samples, compliant with ISO 11290 standard.
- Cromoclin US-AGAR Chromogenic, non-selective culture medium for detection, differentiation, and identification of pathogens responsible for urinary tract infections, using chromogenic substrate mixture that releases distinct colored compounds when degraded by specific microbial enzymes.
- NG-Test CARBA 5 Qualitative immunoassay for detection and differentiation of five most prevalent carbapenemase families (NDM, IMP, VIM, OXA-48, and KPC) and their clinically relevant variants in under 15 minutes from bacterial colonies.
- Bactime (BacTime) System Automated blood culture system detecting CO2 production through color change and pH alterations, including BacTime BC32 and BC128 instruments with associated culture bottles for aerobic, anaerobic, pediatric, and fastidious microorganisms. Uses combination of cationic and polymeric adsorption resins.
- Bactray System of three sets of biochemical tests (Bactray I, II, and III) totaling 30 substrates for identification of Gram-negative bacilli, including oxidase-negative fermenters/non-fermenters and oxidase-positive non-fermenters, with associated online software for remote data access and real-time interpretation.
- Aquateste Coli ONPG/MUG Substrate for quantitative and qualitative detection of total coliforms and Escherichia coli in water samples.
- IRIS Salmonella Alternative method for Salmonella detection in food, feed, and environmental samples, validated for various matrices including powdered milks and infant formulas.
- COMPASS Listeria Method for detection of Listeria in food products and environmental samples, with formulation equivalent to ALOA Agar per FDA-BAM Chapter 10.
- COMPASS Bacillus cereus & Plus Method capable of detecting Bacillus cytotoxicus in food products, offering precision in microbiological control without need for colony confirmation.
- Agar Symphony Culture medium for yeast and mold counting in all food products regardless of water activity, with results in up to 54 hours compared to 5 days for conventional methods.
- EASY STAPH Alternative method for counting coagulase-positive Staphylococcus in food products, animal feed, and environmental samples, providing results in 22 hours instead of 48 hours.
- Lactol Aromatized lactose for lactose intolerance testing, measuring the body's ability to digest lactose through blood glucose measurement.
- Dehydrated Culture Media Portfolio Comprehensive portfolio of dehydrated culture media, supplements, and detection kits for clinical, industrial, and research microbiology applications, including Violet Red Bile, Xilose Caldo, Caldo Fraser, Tetrationato Caldo VB, Uréia Caldo, Água Peptonada, Lactose Gelatina, TSI Agar, Mueller Hinton, MacConkey, Blood Agar, Chocolate Agar, Baird Parker, Columbia CNA, Sabouraud, R2A, and MCTA.
- Biokar Diagnostics Lyophilized Culture Media Lyophilized culture media, reagents, and supplements from Biokar Diagnostics (Solabia Group division), representing European market leadership and 50 years of peptone formulation expertise, distributed exclusively in Brazil and Latin America by Laborclin.
Quantifiable outcome
- Doubling of efficiency and reduction of sample positivity time with BacTime automated blood culture system
- +2 more outcomes
Companies that use Laborclin
Customer profileSegments5 records
Ideal customer profiles5 records
Laborclin technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Laborclin partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Grupo SolabiacoreLaborclin was acquired by the French Solabia Group in March 2020. This acquisition significantly boosted investments in automation, technology, and R&D. Solabia Group, founded in 1972, has over 50 years of experience in pharmaceutical, nutrition, cosmetics, and biotechnology industries with 9 production units across France, Brazil, Israel, and USA, and distribution in 80+ countries.
- Biokar DiagnosticscoreLaborclin serves as the exclusive representative of Biokar Diagnostics in Brazil and Latin America. Biokar is a market leader in Europe for microbiological diagnostic culture media. This partnership strengthened Laborclin's portfolio with high-quality lyophilized culture media, reagents, and supplements.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Laborclin competitors and assessment
Company assessmentDirect peers
- Hardy Diagnostics: US-based specialty manufacturer of culture media and microbiology products for clinical and industrial labs; comparable mid-sized company with similar product focus, distribution model, and customer profile to Laborclin's clinical and industrial segments.
- bioMérieux: Global leader in microbiological diagnostics with directly overlapping product lines including culture media, chromogenic media, blood culture instruments (BacT/ALERT), and identification systems — Laborclin's most direct global competitor across both clinical and industrial microbiology.
Regional players
- Labtest Diagnóstica: Brazilian IVD manufacturer focused on clinical chemistry, hematology, immunology, and urinalysis reagents; competes with Laborclin in the Brazilian clinical diagnostics market and serves the same laboratory customer base domestically.
- Wama Diagnóstica: Brazilian IVD manufacturer with a product portfolio spanning clinical chemistry, immunology, and rapid diagnostics; competes with Laborclin in the Brazilian clinical laboratory market through similar distribution and direct-sales models.
- Gold Analisa Diagnóstica: Brazilian IVD manufacturer offering clinical chemistry, immunoassay, and rapid test products; regional competitor operating in the same Brazilian laboratory diagnostics channel as Laborclin with overlapping clinical-laboratory customers.
Broad incumbents
- Becton, Dickinson and Company (BD): Major IVD incumbent with a microbiology product portfolio including the BD BACTEC automated blood culture system and culture media that compete directly with Laborclin's Bactime and culture media offerings; broader corporate scale enables larger reference-lab enterprise contracts.
- Thermo Fisher Scientific (Microbiology / Oxoid): Through its microbiology division including the legacy Oxoid brand, supplies culture media, reagents, and identification tools globally in the same product categories as Laborclin; competes across both clinical and industrial microbiology segments.
- Merck KGaA / MilliporeSigma: Supplies microbiology culture media, dehydrated media, and reagents under Sigma-Aldrich and MilliporeSigma brands, competing directly with Laborclin and its distributed Biokar Diagnostics line in the culture media category across global markets.
Others
- Copan Diagnostics: Italian-based manufacturer of pre-analytic sample collection devices including flocked, rayon, and transport-medium swabs; Laborclin is a distributor of Copan swabs in Brazil/LATAM (partnership), while Copan also addresses adjacent collection-device opportunities overlapping Laborclin's portfolio.
Emerging players
- HiMedia Laboratories: Indian specialty manufacturer of culture media, microbiological reagents, and identification products; similar emerging-market origin and product focus to Laborclin, addressing global clinical and industrial microbiology demand from a cost-competitive base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Laborclin social profiles
Digital presenceLaborclin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Laborclin leadership team
Management profileNumber of profiles
Profiles1 record
Laborclin funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Laborclin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Laborclin
What does Laborclin do?
Laborclin manufactures and distributes a portfolio of more than 600 microbiological diagnostic products including dehydrated and chromogenic culture media, diagnostic reagents, biochemical identification kits, automated blood culture instruments (BacTime), rapid immunoassays (NG-Test CARBA 5), sterile sample collection swabs, and lyophilized media distributed under the Biokar Diagnostics brand. Products serve clinical analysis laboratories, hospital diagnostics, food and beverage quality control, cosmetics manufacturing, veterinary diagnostics, and biological research across Brazil and Latin America.
Is Laborclin a public or private company?
Laborclin is a private company. It is classified as corporate owned and is currently operating.
When was Laborclin founded?
Laborclin was founded in 1968. It employs 501 to 1,000 people.
Where is Laborclin based?
Laborclin is headquartered in Pinhais, Brazil, in the Latin America region.
How does Laborclin make money?
One revenue line is on record: diagnostic and Microbiology Products.
Who are Laborclin's main competitors?
Direct peers on record are Hardy Diagnostics and bioMérieux. Regional players are Labtest Diagnóstica, Wama Diagnóstica and Gold Analisa Diagnóstica. Broad incumbents are Becton, Dickinson and Company (BD), Thermo Fisher Scientific (Microbiology / Oxoid) and Merck KGaA / MilliporeSigma. Copan Diagnostics is listed as an others. HiMedia Laboratories is listed as an emerging player.
Does Laborclin have an API?
No public API is recorded for Laborclin.
What industry is Laborclin in?
Laborclin's product category is In Vitro Microbiology Diagnostics. Its primary akta.pro industry code is HLAAAKAI, Raw Materials & Critical Reagents Supply Services (media, resins, single-use), with a secondary code of HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing). Its NAICS code is 325413 and its SIC code is 2835.